Desk›Healthcare› Amrutanjan Health Care Ltd
Amrutanjan Health Care Ltd
BSE 590006 · NSE AMRUTANJAN · ISIN INE098F01031 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹515.35
-0.20%
BSE close, 28 August 2026
₹1,506.40 cr
2.9 cr shares · Micro cap
₹781.97 cr
as published
27.6× · 5.00×
EPS ₹18.67 · BV ₹103.07
502.55 / 57.92
₹ cr, as filed
15
2 selected · 13%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -34.8% |
|---|---|
| Against 52-week low | +6.8% |
| Day change | -0.20% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹18.67 |
|---|---|
| Price / earnings | 27.60× |
| Price / book | 5.00× |
| Book value — derived, price ÷ P/B | ₹103.07 |
| Return on equity | 18.12% |
| Operating margin | 7.80% |
| Net margin | 4.24% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 18.12%
- ROE as published
- 18.12%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 102.97 | 4.37 | 1.51 | 7.80% | 4.24% |
| Mar-26 · Q | 149.77 | 16.19 | 5.60 | 15.14% | 10.81% |
| FY25-26 | 502.55 | 57.92 | 20.03 | 16.79% | 11.52% |
Quarter on quarter
- Revenue, quarter on quarter
- -31.2%
- Net profit, quarter on quarter
- -73.0%
- Operating margin, quarter on quarter
- -734 bps
Disclosure profile 15 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Credit Rating | 1 |
| Selected sub-total | 2 |
| Procedural | |
| General | 4 |
| AGM / EGM | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Record Date | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 13 |
| Total | 15 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
15 filings · 2 selected · busiest 2026-08-05
Filing rhythm · the twelve most recent
2026-08-052026-10-09
SelectedProcedural
Filings
15 in the window · 4 earlier on record
-
9 October 2026 ·
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended 30th September 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 September 2026 ·
Closure of Trading Window
Closure of Trading Window for the Quarter Ending 30th September 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results and Scrutinizer Report of 89th Annual General Meeting
AGM/EGM / AGM View filing →
-
23 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 89th Annual General Meeting
AGM/EGM / AGM View filing →
-
28 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
BRSR Report for the financial year ended March 31, 2026.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
28 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report of 89th Annual General Meeting to be held on 23rd September 2026
Others / Reg. 34 (1) Annual Report View filing →
-
12 August 2026 ·
Investor Presentation For The Quarter Ended 30Th June 2026
Investor Presentation for the Quarter Ended 30th June 2026
Company Update / General View filing →
-
11 August 2026 ·
Record Date For The Final Dividend And AGM
Record Date for the Final Dividend and AGM
Corp. Action / Record Date View filing →
-
11 August 2026 ·
Board Meeting Outcome for Financial Results And Outcome Of The Board Meeting
Financial Results and Outcome of the Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
6 August 2026 ·
Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015,
Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
5 August 2026 ·
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2026
Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Board Meeting / Board Meeting View filing →
-
5 August 2026 ·
Commissioning Of New Manufacturing Facility
Commissioning of New Manufacturing Facility
Company Update / General View filing →
-
5 August 2026 ·
Credit Rating
Announcement under Regulation 30 (LODR)- Credit Rating
Company Update / Credit Rating View filing →
-
5 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
RSS feed for Amrutanjan Health Care Ltd · the 50 most recent filings